Global private equity and venture capital news and research

Posts Tagged ‘pharmaceutical’

20 April 2016

Seventure, Lundbeckfond back €14.5m Enterome Series C

tablets-700670_1920 Investors including Seventure and Lundbeckfond Ventures have backed a €14.5m Series C financing round for pharma developer Enterome Bioscience.

11 April 2016

Diversis buys majority stake in Caligor

health healthcare drugs pills medication medical Los Angeles-based private equity firm Diversis Capital has purchased Caligor, a provider of clinical trial supply and logistics services.

1 February 2016

Charterhouse cranks up process for potential Doc Generici sale

tablets-1001224_1920 London-headquartered private equity firm Charterhouse has reportedly contacted investment banks to run a sale of Italian drugmaker Doc Generici, which could see the company valued at up to €700m. Reports from Reuters at the start of December suggested the firm had brought in LEK Consulting to advise on options for the pharmaceutical company, which it[...]

14 December 2015

Carlyle, Hellman & Friedman-backed PPD could hit $8bn valuation through sale, IPO process

drug-1086712_1920 US buyout houses Carlyle and Hellman & Friedman are said to be prepping for a sale or IPO of research business Pharmaceutical Product Development which could value it at up to $8bn.

7 October 2015

European buyout majors eye €700m bidding for French pharma company Cooper

health-846863_1280 European private equity majors including Bridgepoint, BC Partners and Charterhouse Capital are reportedly among firm who could bid about €700m for French pharmaceutical company Cooper.

25 August 2015

Bain Capital backs sterile compound pharma manufacturer QuVa

pills-530372_1280 Bain Capital has bought a majority stake in new sterile compounding pharmacy services platform QuVa Pharma.

22 June 2015

CVC, Temasek take stake in Pamplona-backed pharma company Alvogen

pills-384846_1280 A consortium including CVC Capital Partners and Singapore sovereign investor Temasek is set to buy a controlling stake in Pamplona-backed pharmaceutical company Alvogen.

16 June 2015

Sequoia backs Indian pharma business La Renon with $15.5m

aspirin-156974-m Sequoia Capital has invested INR1bn ($15.5m) in Indian pharmaceutical research, marketing and manufacturing business La Renon Healthcare.

10 June 2015

Fulcrum Venture India hits INR1bn final close for second healthcare, pharma fund

rupees-533387-m Early-stage investor Fulcrum Venture India has beaten its target for its latest healthcare and pharmaceutical fund by closing the vehicle on INR1bn ($15.6m).

1 May 2015

VC-backed Blueprint Medicines floats raising $147m

news_blueprint_lrg Third Rock Ventures-backed enzyme specialist Blueprint Medicines Corp has launched its IPO on the New York Stock Exchange raising $147m.

Page 1 of 2112345...1020...Last »

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016